Search

Displaying results 1371 - 1380 of 10000 in total
  1. Drug

    Urea C-13

    go.drugbank.com/drugs/DB09510
    ApprovedInvestigational

    If gastric urease from H. pylori is present, urea is split to form CO2 and NH3 at the interface between the gastric epithelium and lumen and 13CO2 is absorbed into the blood and exhaled in the breath. … To detect H. pylori, urea labeled with 13C is swallowed by the patient.

    Products: UBIT Tablet 100mg
  2. Indication

    Metastatic pancreatic endocrine carcinoma

    go.drugbank.com/conditions/DBCOND0022757
    Drugs: Capecitabine
    Synonyms: Metastasis from pancreatic endocrine carcinoma, Metastasis from pancreatic endocrine carcinoma (disorder)
  3. Drug

    Dyphylline

    go.drugbank.com/drugs/DB00651
    ApprovedWithdrawn

    Dyphylline is a theophylline derivative with broncho- and vasodilator properties. It is typically used in the management of asthma, cardiac dyspnea, and bronchitis.

    Mixtures: Dyphylline and GuaifenesinCategories: Xanthines and Adrenergics, diprophylline and adrenergics
  4. Drug

    Glucosamine

    go.drugbank.com/drugs/DB01296
    Approved

    Osteoarthritis (OA) is a progressive and degenerative joint disease marked by loss of cartilage, bone changes, and synovial membrane inflammation. … [A231894,A232289] It is currently not approved as a prescription product by the FDA, but is widely available over the counter.

    Mixtures: Bee Venom Joint And Bone Therapy Drops, Blackmores Joint Formula with Glucosamine and ChondroitinCategories: Antiinflammatory and Antirheumatic Products, Antiinflammatory and Antirheumatic Products, Non-Steroids
  5. Drug

    Nedocromil

    go.drugbank.com/drugs/DB00716
    Approved

    A pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with asthma, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets.

    Categories: Decongestants and AntiallergicsProducts: Tilade Inhaler 2mg/aem
  6. Drug

    Erythropoietin

    go.drugbank.com/drugs/DB00016
    ApprovedInvestigational

    The biosimilar is approved by the FDA and EMA as a safe, effective and affordable biological product and displays equivalent clinical efficacy, potency, and purity to the reference product [A7504]. … Epoetin alfa (Epoge) was developed by Amgen Inc. in 1983 as the first rhEPO commercialized in the United States, followed by other alfa and beta formulations.

    Categories: Blood and Blood Forming Organs, Amino Acids, Peptides, and ProteinsProducts: RECORMON® SOLUCIONINYECTABLE 30000 UI/0.6 ML, RECORMON SOLUCION INYECTABLE5000 UI /03ML
  7. Drug

    Clorazepic acid

    go.drugbank.com/drugs/DB00628
    ApprovedIllicit

    [A256683,T883] The concomitant use of clorazepate and opioids may result in profound sedation, respiratory depression, coma, and death. … Also, the use of clorazepate exposes users to users to the risks of abuse, misuse, and addiction, and its continued use may lead to significant physical dependence.

    Categories: Benzodiazepines and benzodiazepine derivativesProducts: Tranxene Cap 15mg, Novo-clopate Cap 15mg
  8. Drug

    Semaglutide

    go.drugbank.com/drugs/DB13928
    ApprovedInvestigational

    Semaglutide works by binding to and activating the GLP-1 receptor, thereby stimulating insulin secretion and reducing blood glucose. … [A31421,L8681] Other members of this drug class include [Exenatide] and [Liraglutide]. Semaglutide was developed by Novo Nordisk and approved by the FDA for subcutaneous injection in December 2017.

    Categories: Alimentary Tract and Metabolism, Amino Acids, Peptides, and ProteinsProducts: Rybelsus 14mg Tablet, RYBELSUS® TABLET 14MG
  9. Drug

    Pyridostigmine

    go.drugbank.com/drugs/DB00545
    ApprovedInvestigational

    By inhibiting the breakdown of acetylcholine in the neuromuscular junction, they increase signalling and relieve symptoms. … muscle tone loss, muscle weakness, and fatigue.

    Products: Mestinon Tablet 10mg, Regonol Inj 5mg/ml
  10. Drug

    Brigatinib

    go.drugbank.com/drugs/DB12267
    ApprovedInvestigational

    [A31313] Brigatinib was developed by Ariad Pharmaceuticals, a subsidiary of Takeda Pharmaceutical Company Limited, and FDA-approved on April 28, 2017.[L1026] … Brigatinib, originally named AP26113, is a reversible dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).

    Categories: Antineoplastic and Immunomodulating AgentsProducts: ALUNBRIG FILM-COATED TABLET 180mg, Alunbrig (Brigatinib) 180mg Film-Coated Tablet